3ZQ0 Stock Overview
Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Ayurcann Holdings Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.017 |
52 Week High | CA$0.05 |
52 Week Low | CA$0.0005 |
Beta | 1.92 |
1 Month Change | -38.18% |
3 Month Change | 70.00% |
1 Year Change | -27.66% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -86.63% |
Recent News & Updates
Recent updates
Shareholder Returns
3ZQ0 | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | 70.0% | -2.6% | -0.4% |
1Y | -27.7% | -27.1% | 5.0% |
Return vs Industry: 3ZQ0 underperformed the German Pharmaceuticals industry which returned -25.5% over the past year.
Return vs Market: 3ZQ0 underperformed the German Market which returned 6.2% over the past year.
Price Volatility
3ZQ0 volatility | |
---|---|
3ZQ0 Average Weekly Movement | 72.6% |
Pharmaceuticals Industry Average Movement | 6.1% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.3% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 3ZQ0's share price has been volatile over the past 3 months.
Volatility Over Time: 3ZQ0's weekly volatility has decreased from 205% to 73% over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Igal Sudman | https://ayurcann.com |
Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. It offers extraction, processing, and co-manufacturing of pharma grade cannabis to produce various derivative cannabis products in the medical and recreational markets. The company sells product under the Fuego, H&S, XPLOR, JOINTS and BRAVO6 brands.
Ayurcann Holdings Corp. Fundamentals Summary
3ZQ0 fundamental statistics | |
---|---|
Market cap | €4.62m |
Earnings (TTM) | -€3.50m |
Revenue (TTM) | €13.32m |
0.3x
P/S Ratio-1.3x
P/E RatioIs 3ZQ0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
3ZQ0 income statement (TTM) | |
---|---|
Revenue | CA$19.64m |
Cost of Revenue | CA$13.26m |
Gross Profit | CA$6.38m |
Other Expenses | CA$11.54m |
Earnings | -CA$5.16m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.027 |
Gross Margin | 32.50% |
Net Profit Margin | -26.28% |
Debt/Equity Ratio | 21.0% |
How did 3ZQ0 perform over the long term?
See historical performance and comparison